544 related articles for article (PubMed ID: 8592950)
1. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
[TBL] [Abstract][Full Text] [Related]
2. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats.
Ma YF; Jee WS; Ke HZ; Lin BY; Liang XG; Li M; Yamamoto N
J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472
[TBL] [Abstract][Full Text] [Related]
3. Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure.
Tang LY; Jee WS; Ke HZ; Kimmel DB
J Bone Miner Res; 1992 Sep; 7(9):1093-104. PubMed ID: 1414502
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
[TBL] [Abstract][Full Text] [Related]
5. Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats.
Jee WS; Lin BY; Ma YF; Ke HZ
J Bone Miner Res; 1995 Jun; 10(6):963-70. PubMed ID: 7572321
[TBL] [Abstract][Full Text] [Related]
6. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
Baumann BD; Wronski TJ
Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats.
Qi H; Li M; Wronski TJ
J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone.
Ma Y; Jee WS; Yuan Z; Wei W; Chen H; Pun S; Liang H; Lin C
J Bone Miner Res; 1999 Mar; 14(3):439-48. PubMed ID: 10027909
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
Rhee Y; Won YY; Baek MH; Lim SK
J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
[TBL] [Abstract][Full Text] [Related]
10. Effects of parathyroid hormone (1-34) on tibia in an adult rat model for chronic alcohol abuse.
Sibonga JD; Iwaniec UT; Shogren KL; Rosen CJ; Turner RT
Bone; 2007 Apr; 40(4):1013-20. PubMed ID: 17204460
[TBL] [Abstract][Full Text] [Related]
11. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
[TBL] [Abstract][Full Text] [Related]
12. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
[TBL] [Abstract][Full Text] [Related]
13. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
Wronski TJ; Yen CF; Qi H; Dann LM
Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497
[TBL] [Abstract][Full Text] [Related]
15. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
Zhou H; Shen V; Dempster DW; Lindsay R
J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
[TBL] [Abstract][Full Text] [Related]
16. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
[TBL] [Abstract][Full Text] [Related]
17. Risedronate did not block the maximal anabolic effect of PTH in aged rats.
Yao W; Su M; Zhang Q; Tian X; Setterberg RB; Blanton C; Lundy MW; Phipps R; Jee WS
Bone; 2007 Nov; 41(5):813-9. PubMed ID: 17716965
[TBL] [Abstract][Full Text] [Related]
18. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
Takano Y; Tanizawa T; Mashiba T; Endo N; Nishida S; Takahashi HE
J Bone Miner Res; 1996 Feb; 11(2):169-77. PubMed ID: 8822340
[TBL] [Abstract][Full Text] [Related]
19. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model.
Mosekilde L; Danielsen CC; Søgaard CH; McOsker JE; Wronski TJ
Bone; 1995 Feb; 16(2):223-30. PubMed ID: 7756051
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
Ma YF; Lin BY; Jee WS; Lin CH; Chen YY; Ke HZ; Li XJ
J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]